BLCM logo

Bellicum Pharmaceuticals (BLCM) Depreciation And Amortization

Annual D&A

$11.00 K
-$127.00 K-92.03%

December 31, 2022

Summary

Performance

1-Year Change

-92.03%

3-Year Change

-99.87%

5-Year Change

-99.69%

15-Year Change

-99.69%

BLCM Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$8.51 M
BLCM annual depreciation & amortization is currently -99.87% below its historical high of $8.51 million

3-Year Low

$11.00 K
BLCM annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BLCM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BLCM next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$28.48 M
BLCM annual total expenses is $28.48 million

Annual Operating Expenses

$28.48 M
BLCM annual total operating expenses is $28.48 million

Annual Cost Of Goods Sold

-
BLCM annual cost of goods sold value is unknown

Annual Interest Expense

-
BLCM annual interest expense value is unknown

Quarterly D&A

$2000.00
$0.000.00%

September 1, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

+100%

3-Year Change

-99.53%

5-Year Change

-99.89%

BLCM Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.28 M
BLCM quarterly depreciation & amortization is currently -99.91% below its historical high of $2.28 million

3-Year Low

$1000.00
BLCM quarterly depreciation & amortization is currently +100.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
BLCM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
BLCM next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$1.77 M
BLCM quarterly total expenses is $1.77 million

Quarterly Operating Expenses

$1.77 M
BLCM quarterly total operating expenses is $1.77 million

Quarterly Cost Of Goods Sold

-
BLCM quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
BLCM quarterly interest expense value is unknown

TTM D&A

$9000.00
+$1000.00+12.50%

September 1, 2023

Summary

Performance

3-Month Change

+12.5%

1-Year Change

-62.5%

3-Year Change

-99.75%

5-Year Change

-99.89%

BLCM TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$8.51 M
BLCM TTM depreciation & amortization is currently -99.89% below its historical high of $8.51 million

3-Year Low

$8000.00
BLCM TTM depreciation & amortization is currently +12.50% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
BLCM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
BLCM next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$28.48 M
BLCM annual total expenses is $28.48 million

Annual Operating Expenses

$28.48 M
BLCM annual total operating expenses is $28.48 million

TTM Cost Of Goods Sold

-
BLCM TTM cost of goods sold value is unknown

TTM Interest Expense

-
BLCM TTM interest expense value is unknown

BLCM Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-92.0%+100.0%-62.5%
3 y3 years-99.9%-99.5%-99.8%
5 y5 years-99.7%-99.9%-99.9%

BLCM Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.0%at low-86.7%-50.0%-93.5%-11.1%
5 y5-year-99.9%at low-99.9%-50.0%-99.9%-11.1%
alltimeall time-99.9%at low-99.9%-50.0%-99.9%-11.1%

Bellicum Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2023
-
$2000.00(0.0%)
$9000.00(+12.5%)
Jun 2023
-
$2000.00(-33.3%)
$8000.00(-11.1%)
Mar 2023
-
$3000.00(+50.0%)
$9000.00(-18.2%)
Dec 2022
$11.00 K(-92.0%)
$2000.00(+100.0%)
$11.00 K(-54.2%)
Sep 2022
-
$1000.00(-66.7%)
$24.00 K(-44.2%)
Jun 2022
-
$3000.00(-40.0%)
$43.00 K(-31.7%)
Mar 2022
-
$5000.00(-66.7%)
$63.00 K(-54.3%)
Dec 2021
$138.00 K(-92.6%)
$15.00 K(-25.0%)
$138.00 K(-70.7%)
Sep 2021
-
$20.00 K(-13.0%)
$471.00 K(-46.4%)
Jun 2021
-
$23.00 K(-71.3%)
$879.00 K(-34.0%)
Mar 2021
-
$80.00 K(-77.0%)
$1.33 M(-28.9%)
Dec 2020
$1.87 M(-78.0%)
$348.00 K(-18.7%)
$1.87 M(-47.3%)
Sep 2020
-
$428.00 K(-10.1%)
$3.56 M(-31.9%)
Jun 2020
-
$476.00 K(-23.5%)
$5.23 M(-25.7%)
Mar 2020
-
$622.00 K(-69.4%)
$7.03 M(-17.4%)
Dec 2019
$8.51 M(+27.0%)
$2.03 M(-3.1%)
$8.51 M(+3.0%)
Sep 2019
-
$2.10 M(-8.0%)
$8.26 M(+4.4%)
Jun 2019
-
$2.28 M(+8.6%)
$7.91 M(+7.3%)
Mar 2019
-
$2.10 M(+17.8%)
$7.37 M(+10.0%)
Dec 2018
$6.70 M
$1.78 M(+1.8%)
$6.70 M(+12.5%)
DateAnnualQuarterlyTTM
Sep 2018
-
$1.75 M(+0.7%)
$5.96 M(+17.2%)
Jun 2018
-
$1.74 M(+21.9%)
$5.08 M(+20.7%)
Mar 2018
-
$1.43 M(+37.1%)
$4.21 M(+18.1%)
Dec 2017
$3.56 M(+54.6%)
$1.04 M(+18.7%)
$3.56 M(+11.0%)
Sep 2017
-
$876.00 K(+1.2%)
$3.21 M(+6.9%)
Jun 2017
-
$866.00 K(+10.7%)
$3.00 M(+14.4%)
Mar 2017
-
$782.00 K(+13.8%)
$2.63 M(+13.8%)
Dec 2016
$2.31 M(+92.3%)
$687.00 K(+2.8%)
$2.31 M(+12.5%)
Sep 2016
-
$668.00 K(+36.9%)
$2.05 M(+15.4%)
Jun 2016
-
$488.00 K(+5.4%)
$1.77 M(+21.1%)
Mar 2016
-
$463.00 K(+7.7%)
$1.47 M(+22.3%)
Dec 2015
$1.20 M(+79.8%)
$430.00 K(+9.1%)
$1.20 M(+26.1%)
Sep 2015
-
$394.00 K(+120.1%)
$951.00 K(+31.9%)
Jun 2015
-
$179.00 K(-8.7%)
$721.00 K(+2.4%)
Mar 2015
-
$196.00 K(+7.7%)
$704.00 K(+5.5%)
Dec 2014
$667.00 K(+13.6%)
$182.00 K(+11.0%)
$667.00 K(+37.5%)
Sep 2014
-
$164.00 K(+1.2%)
$485.00 K(+51.1%)
Jun 2014
-
$162.00 K(+1.9%)
$321.00 K(+101.9%)
Mar 2014
-
$159.00 K
$159.00 K
Dec 2013
$587.00 K(+409.1%)
-
-
Dec 2012
$115.30 K
-
-

FAQ

  • What is Bellicum Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals annual D&A year-on-year change?
  • What is Bellicum Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals quarterly D&A year-on-year change?
  • What is Bellicum Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals TTM D&A year-on-year change?

What is Bellicum Pharmaceuticals annual depreciation & amortization?

The current annual D&A of BLCM is $11.00 K

What is the all time high annual D&A for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high annual depreciation & amortization is $8.51 M

What is Bellicum Pharmaceuticals annual D&A year-on-year change?

Over the past year, BLCM annual depreciation & amortization has changed by -$127.00 K (-92.03%)

What is Bellicum Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of BLCM is $2000.00

What is the all time high quarterly D&A for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high quarterly depreciation & amortization is $2.28 M

What is Bellicum Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, BLCM quarterly depreciation & amortization has changed by +$1000.00 (+100.00%)

What is Bellicum Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of BLCM is $9000.00

What is the all time high TTM D&A for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high TTM depreciation & amortization is $8.51 M

What is Bellicum Pharmaceuticals TTM D&A year-on-year change?

Over the past year, BLCM TTM depreciation & amortization has changed by -$15.00 K (-62.50%)